FDA Investigator Johnna L Bleem

Johnna L Bleem has inspections in 1 countries as of 13 Oct 2023. Johnna L Bleem has collaborated with a combinined 2286 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

13 Oct 2023

Investigator Role:

FDA Investigator

Redica ID:

100007944

Country:

United States of America

Co-Investigator(s):

Alberto A Viciedo, Alice S Tsao, Alison N Stieg, Amy M Codella, Amy M Cramer, Amy N Chen, Anastasia I Onuorah, Anita R Michael, Atul J Agrawal, Benton M Ketron, Bijoy Panicker, Brian J Ryan, Brooke K Higgins, Brooke K Seeman, Bruce G Cooper, Carolyn J Cook, CDR Ileana Barreto Pettit, CDR John Mastalski, Chaltu N Wakijra, Charanjeet Jassal, Christopher Janik, Craig D Zagata, Daniel L Aisen, David M Mcnew, Demitria J Xiradakis, Dennis L Doupnik, Diane T Bargo, Diane T O'brien, Dien N Nguyen, Douglas A Campbell, Douglas C Kovacs, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Elaine E Gilfillan, Emest F Bizjak, Erika E Englund, PhD, Erin L Nagel, Felix Maldonado, Gam S Zamil, Guerlain Ulysse, Harperd, Harry J Brewer, Helen B Ricalde, Hilary K Wagner, James A Liubicich, James D Bridges, James M Mason, James R Birkenstamm, Janet A Rajan, Jazmine N Brown, Jeanette L Mcginnis, Joel R Merriman, John A Podsadowski, John P Mistler, Jonathan W Chapman, Jose O Hernandez, Joseph J Vannelli, Juan Rjimenez Garcia, Kames A Liubicich, Karen L Kosar, Katelyn Astaub Zamperini, Kathryn A Nagy, Kenneth G Klobus, Kevin A Gonzalez, Kim M Downing, King, Ko U Min, Kshitij A Patkar, Lauren E Blaser, Lawrence J Stringer, Linda M Sacco, Marcellinus D Dordunoo, Marcus A Ray, Margaret E Sarles, Marlene L Davis, Mary Alice B Garlipp, Massoud Motamed, Matthew D Schnittker, Melissa J Garcia, Melissa T Roy, Meyer J Slobotsky, Michael A Charles, Michael L Casner, Michael W Burd, Michelle Marsh, Mindy M Chou, Nancy M Espinal, Nealie C Newberger, Nicholas C Mendiola, Niketa Patel, Parul M Patel, Patrick C Klotzbuecher, Paul L Bellamy, Paul Mouris, Paula J Bretz, Pratik S Upadhyay, DDC, Qin Xu, Rabin N Ghoshal, Rachael A Moliver, Rajiv R Srivastava, Randi Lynn Bodoh, Rebecca E Dombrowski, Richard K Glabach, Robert C Steyert, Robert J Martin, Russ E Davis, Sasha M Latonis, Satheesh Thomas, Sean R Marcsisin, Simone E Pitts, Sinai Davis, Sneha Patel, Sneha S Patel, Sony Mathews, State Agency, Stephanie Mangigian, MS/OSH, RN, Stephen J Mottola, Steven J Libal, Syeda N Mahazabin, Tamika White, Tamil Arasu, PhD, Tanya R Syffrard, Tekalign Wondimu, Thomas J Arista, Toyin B Oladimeji, Wendy G Tan, PhD, William A Warnick, William J Leonard, William L Bargo, Yiyue Zhang (nmi), PhD, Yvesna C Blaise

Johnna L Bleem's Documents

Publish Date	Document Type	Title
July, 2019	FDA 483	Athenex, Inc. - Form 483, 2019-07-11
May, 2019	FDA 483	Unither Manufacturing LLC - Form 483, 2019-05-22
August, 2021	FDA 483	The Skin Atelier, Inc. - Form 483, 2021-08-25
March, 2020	EIR	Safetec of America, Inc. - EIR, 2020-03-06
September, 2020	EIR	F. M. Howell & Company - EIR, 2020-09-08
May, 2019	FDA 483 Response	Unither Manufacturing LLC - Form 483R, 2019-05-22
February, 2022	FDA 483	Frontage Laboratories, Inc. - Form 483, 2022-02-18
June, 2021	FDA 483	Mentholatum Company, The - Form 483, 2021-06-17
April, 2019	FDA 483	Aurohealth LLC - Form 483, 2019-04-11
April, 2019	FDA 483 Response	Aurohealth LLC - Form 483R, 2019-05-02
January, 2020	EIR	Unither Manufacturing LLC - EIR, 2020-01-10
May, 2019	EIR	Unither Manufacturing LLC - EIR, 2019-05-22
July, 2021	FDA 483	Reliant Compounded Solutions Monroe, LLC - Form 483, 2021-07-27
August, 2019	EIR	Fresenius Kabi USA, LLC - EIR, 2019-08-12
July, 2019	EIR	Athenex, Inc. - EIR, 2019-07-11
December, 2021	FDA 483	Aurora Labs, LLC - Form 483, 2021-12-03
August, 2019	FDA 483	Fresenius Kabi USA, LLC - Form 483, 2019-08-12
August, 2019	FDA 483 Response	Fresenius Kabi USA, LLC - Form 483R, 2019-10-21
March, 2020	FDA 483	Safetec of America, Inc. - Form 483, 2020-03-06
November, 2019	FDA 483	Bausch & Lomb Incorporated - Form 483, 2019-11-25
May, 2021	FDA 483	Pine Pharmaceuticals, LLC - Form 483, 2021-05-14
March, 2022	FDA 483	Elementis SRL, Inc. - Form 483, 2022-03-17
February, 2022	EIR	Frontage Laboratories, Inc. - EIR, 2022-02-18
February, 2022	FDA 483 Response	Frontage Laboratories, Inc. - Form 483R, 2022-03-11
May, 2022	FDA 483	Mylan Pharmaceuticals Inc. - Form 483, 2022-06-22
September, 2021	FDA 483	Arkema Inc. - Form 483, 2021-09-22

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more